Michel Pletschette

Munich, BY, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Vaccine preparedness for Bundibugyo virus and lessons learned.

Vaccine preparedness for Bundibugyo virus and lessons learned.

Journal: NPJ vaccines

Published: June 19, 2026

Pulmonary artery pseudoaneurysm as a neglected manifestation of pulmonary mucormycosis: a retrospective observational study.

Pulmonary artery pseudoaneurysm as a neglected manifestation of pulmonary mucormycosis: a retrospective observational study.

Journal: BMC infectious diseases

Published: October 21, 2025

The second national anti-tuberculosis drug resistance survey in Tanzania, 2017-2018.

The second national anti-tuberculosis drug resistance survey in Tanzania, 2017-2018.

Journal: Tropical medicine & international health : TM & IH

Published: September 11, 2022

Cystic pulmonary tuberculosis: A rare form of an ancient disease.

Cystic pulmonary tuberculosis: A rare form of an ancient disease.

Journal: Respirology case reports

Published: May 16, 2022

Phylogenetic lineages of tuberculosis isolates and their association with patient demographics in Tanzania.

Phylogenetic lineages of tuberculosis isolates and their association with patient demographics in Tanzania.

Journal: BMC genomics

Published: February 09, 2022

Whole genome sequencing-based drug resistance predictions of multidrug-resistant Mycobacterium tuberculosis isolates from Tanzania.

Whole genome sequencing-based drug resistance predictions of multidrug-resistant Mycobacterium tuberculosis isolates from Tanzania.

Journal: JAC-antimicrobial resistance

Published: November 10, 2021

From first to second wave: follow-up of the prospective COVID-19 cohort (KoCo19) in Munich (Germany).

From first to second wave: follow-up of the prospective COVID-19 cohort (KoCo19) in Munich (Germany).

Journal: BMC infectious diseases

Published: May 16, 2021

Prevalence and Risk Factors of Infection in the Representative COVID-19 Cohort Munich.

Prevalence and Risk Factors of Infection in the Representative COVID-19 Cohort Munich.

Journal: International journal of environmental research and public health

Published: February 18, 2021

Lessons from the COVID-19 Pandemic-Unique Opportunities for Unifying, Revamping and Reshaping Epidemic Preparedness of Europe's Public Health Systems.

Lessons from the COVID-19 Pandemic-Unique Opportunities for Unifying, Revamping and Reshaping Epidemic Preparedness of Europe's Public Health Systems.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Published: November 05, 2020

Non-inferiority versus superiority trial design for new antibiotics in an era of high antimicrobial resistance: the case for post-marketing, adaptive randomised controlled trials.

Non-inferiority versus superiority trial design for new antibiotics in an era of high antimicrobial resistance: the case for post-marketing, adaptive randomised controlled trials.

Journal: The Lancet. Infectious diseases

Published: October 02, 2018

Criteria for discharge of patients with Ebola virus diseases in high-income countries.

Criteria for discharge of patients with Ebola virus diseases in high-income countries.

Journal: The Lancet. Global health

Published: September 03, 2015

Are adaptive randomised trials or non-randomised studies the best way to address the Ebola outbreak in west Africa?

Are adaptive randomised trials or non-randomised studies the best way to address the Ebola outbreak in west Africa?

Journal: The Lancet. Infectious diseases

Published: April 18, 2015

Showing 1-12 of 17

Last Updated: 09/26/2026